Clinical ResearchInterventional CardiologyA Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions: 12-Month Outcomes From the ENDEAVOR IV Trial
Key Words
Abbreviations and Acronyms
Cited by (0)
The ENDEAVOR IV clinical trial was funded by Medtronic CardioVascular, Santa Rosa, California. Dr. Leon has served as a consultant to Volcano Corporation, Abbott Vascular, Boston Scientific, Cordis, and Medtronic, Inc. Dr. Mauri has served as a consultant to Abbott, Boston Scientific, Cordis, and Medtronic, Inc. Dr. Popma has received research grants from Cordis, Boston Scientific, Medtronic, Abbott Vascular, Biosensors, and ev3; has served as a consultant for Medtronic, Boston Scientific, Cordis, Abbott Vascular, and Lilly; and has served as a speaker for Pfizer, Bristol-Myers Squibb, Sanofi, Lilly, Boston Scientific, Medtronic, Cordis, and The Medicines Co. Dr. O'Shaughnessy has received research grants from Medtronic, Inc.and Boston Scientific, and is on the advisory board and Speakers' Bureau of Boston Scientific. Dr. Overlie has served as a clinical investigator for Abbott Vascular, Boston Scientific, Cordis, and Medtronic, Inc. Dr. Solomon is a registered speaker for the Medtronic Corporation. Dr. Douglas is a research investigator for Medtronic, Cordis, Boston Scientific, St. Jude, and Abbott. Dr. Caputo is a consultant to Boston Scientific and Cordis, and is on the Speakers' Bureau of Medtronic and Abbott. Dr. Kirtane has served as a consultant and speaker for Medtronic CardioVascular, Abbott Vascular, and Boston Scientific. Dr. Fitzgerald has served as a consultant for Abbott, Boston Scientific, Cordis, EndoTex, St. Jude Medical, Biosensor, ev3, Medtronic, Inc., GlaxoSmithKline, XTENT, ATI, Volcano Corporation, Novadaq, AorTx, CardioMind, Cytograft Tissue Engineering, FlowCardia, Cardio-Optics, Optics, CardioMind, RTI Medical, SurModics, Hospira, and CatherosMed. Dr. Thompson is a full-time employee and stockholder of Medtronic CardioVascular. Dr. Kandzari receives research/grant support and consulting honoraria from Medtronic CardioVascular, Inc.and Cordis Corporation.